Income StatementBalance SheetCash FlowSegments
Roivant Sciences logo

Roivant Sciences Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Roivant Sciences holds $5.7B in total assets. Shareholders' equity is $4.5B against $107.4M in total debt. Cash and equivalents total $1.4B. The current ratio is 18.37 and debt-to-equity is 0.024. Based on the Q1 2026 filing.

Total Assets$5.7BTotal Stockholders Equity$4.5BLong Term Debt$311.7MCash And Equivalents$1.4BTotal Current Assets$5.2BTotal Current Liabilities$281.2M
Latest FilingQ1 2026
Report Date2026-05-20
Market Cap$20.4B

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$23.7M$23.7M$11.6M$15.1M$13.3M$18.0M
Accrued expenses$39.3M$114.3M$26.5M$26.4M$38.1M$205.8M
Accrued Manufacturing Costs$39.3M$53.9M$26.5M$26.4M$38.1M—
Other Commercial Liabilities$104.3M$114.3M$88.7M$108.3M$118.0M$205.8M
Accrued Liabilities, Current$104.3M$114.3M$88.7M$108.3M$118.0M$205.8M
Deferred income$3.0M$1.2M——$3.1M—
Compensation and benefits$39.3M$53.9M$26.5M$26.4M$38.1M—
Other accrued liabilities$3.6M$1.2M$4.2M$1.5M$10.2M$583.0K
Deferred revenue$3.0M$1.2M——$3.1M—
Derivative Liabilities - Fair Value—$10.0M——$0.0—
Income taxes payable$576.0K$416.0K$21.3M$21.3M$7.2M$45.7M
Note payable to DIRECTV$3.6M$1.2M$4.2M$1.5M$10.2M$583.0K
Operating lease liabilities, current$9.8M$9.8M$9.4M$9.0M$10.4M$11.1M
Other current liabilities—$0.0——$26.0K—
Total current liabilities$141.5M$149.4M$113.9M$133.9M$152.0M$281.2M

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$4.7B$4.6B$4.6B$4.8B$4.9B$5.0B
Accumulated other comprehensive income (loss)$8.1M$9.4M$17.1M$19.6M$20.6M$4.4M
Common stock$7.0B$0.0$7.0B$7.0B$7.0B$0.0
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00—
Common Stock Shares Issued719.6M695.9M682.2M689.7M709.7M—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$0.0$0.0$0.0$0.0$0.0$0.0
Noncontrolling interests$346.5M$499.6M$470.3M$443.1M$705.0M$765.0M
Retained earnings$460.4M$116.1M-$315.6M-$429.1M-$695.0M-$501.8M
Share-Based Payment - Nonvested Awards (Number)—348.5K000—
Total liabilities and stockholders' equity$5.8B$5.4B$5.0B$5.1B$5.2B$5.7B
Total stockholders' equity$5.2B$4.7B$4.3B$4.4B$4.3B$4.5B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cash and cash equivalents$99.1M$94.0M$94.8M$102.2M$91.9M$1.4B
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)$2.0B$2.7B$1.2B$1.2B$1.5B—
Cash Cash Equivalents And Short Term Investments$5.1B$4.9B$4.5B$4.4B$4.5B—
Litigation settlement receivable—$0.0———$770.2M
Short- term Investments$3.2B$2.2B$3.3B$3.1B$3.1B$2.9B
Other current assets$217.5M$113.2M$112.6M$125.8M$129.9M$105.3M
Derivative assets—$10.0M——$0.0—
Prepaid expenses and other current assets$57.7M$113.2M$112.6M$125.8M$129.9M$105.3M
Restricted cash$3.1M$2.4M$2.3M$2.3M$2.6M—
Short-term investments$3.2B$2.2B$3.3B$3.1B$3.1B$2.9B
Total current assets$5.4B$5.0B$4.6B$4.5B$4.7B$5.2B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Debt Maturity - 2025———$14.0M$14.0M—
Debt Maturity - 2027———$10.1M$10.0M—
Operating lease liabilities, non-current$90.5M$90.3M$90.3M$89.8M$98.5M$96.3M
Operating Lease Liabilities (Total)—$100.2M———$107.4M
Other non-current liabilities$307.0K$22.0K$228.0K$170.0K$677.0K$70.0K
Total liabilities$256.4M$249.7M$216.7M$257.1M$251.1M$416.3M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred Tax Assets and Other Non-Current Assets$33.9M$32.9M$31.1M$27.8M$34.6M$40.9M
Total investment securities$290.0M$302.9M$283.8M$412.3M$433.9M$408.0M
Net Investment in Lease$90.9M$89.0M$87.1M$85.1M$83.6M$80.4M
Operating lease right-of-use assets$90.9M$89.0M$87.1M$85.1M$83.6M$80.4M
Other non-current assets$33.9M$32.9M$31.1M$27.8M$34.6M$40.9M
Operating lease right-of-use assets$90.9M$89.0M$87.1M$85.1M$83.6M$80.4M
Operating Lease Right-of-Use Assets in Other Assets$90.9M$89.0M$87.1M$85.1M$83.6M$80.4M
Other non-current assets$33.9M$32.9M$31.1M$27.8M$34.6M$40.9M
Property and equipment, net$13.6M$12.1M$14.9M$25.7M$13.4M$12.0M
Software and Technology Licenses, Net$33.9M$32.9M$31.1M$27.8M$34.6M$40.9M
Total assets$5.8B$5.4B$5.0B$5.1B$5.2B$5.7B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross Assets/Liabilities—$10.0M——$0.0—
Research and development expenses$53.5M$45.8M$49.8M$58.9M$55.7M—
Cash and cash equivalents, end of period$2.0B$2.7B$1.2B$1.2B$1.5B—
Common stock, par value (in dollars per share)$0.0$0.0$0.0$0.0$0.0—
Common stock, shares authorized (in shares)$7.0B$7.0B$7.0B$7.0B$7.0B—
Common stock, shares issued (in shares)$719.6M$695.9M$682.2M$689.7M$709.7M—
Common Stock, Shares, Outstanding$719.6M$695.9M$682.2M$689.7M$709.7M—
Derivative Liability—$10.0M——$0.0—
Investments Fair Value Disclosure$290.0M$302.9M$283.8M$412.3M$433.9M$408.0M
Lessee Operating Lease Discount Rate————$0.1—
Liability instruments measured at fair value$24.1M$10.0M$12.3M$33.3M$0.0$0.0
Milestone receivable from sale of discontinued operations$75.0M—————
Noncontrolling interests in subsidiaries$346.5M$499.6M$470.3M$443.1M$705.0M$765.0M
Money Market Funds At Carrying Value$1.9B$2.6B$1.1B$1.1B$1.4B—
Other accrued liabilities$11.6M$14.6M$12.4M$23.0M$24.2M—
Other—$0.0——$26.0K—
Purchase Obligation———$39.1M$39.1M—
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number—$348.5K$0.0$0.0$0.0—
Income tax payable, noncurrent—$0.0———$38.7M
Purchase Commitments - Due Next Year———$1.0M$300.0K—
Purchase Obligation———$39.1M$39.1M—
Unrecorded Unconditional Purchase Obligation———$0.0$800.0K—
Weighted-Average Discount Rate————8.5%—